Patent · US Expired

Death domain containing receptor 4 nucleic acids and methods

US6342363B1 · kind B1 · utility

29Cited by
0References
303Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 27, 1998
Grant dateJan 29, 2002
Priority date
Expiry dateJan 27, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/70578
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.